Jun 18 |
Relmada Therapeutics Announced Publication of Results from the Phase 3 Reliance I Study of REL-1017 in The Journal of Clinical Psychiatry
|
Jun 10 |
Relmada Therapeutics to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference
|
Jun 5 |
Keurig Dr Pepper To Rally Around 18%? Here Are 10 Top Analyst Forecasts For Wednesday
|
Jun 3 |
Relmada Therapeutics to Participate in the 2024 Jefferies Global Healthcare Conference
|
May 28 |
7 Penny Biotech Stocks to Triple Your Investment
|
May 11 |
Relmada Therapeutics, Inc. (NASDAQ:RLMD) Q1 2024 Earnings Call Transcript
|
May 10 |
Relmada Therapeutics, Inc. (RLMD) Q1 2024 Earnings Call Transcript
|
May 9 |
Relmada Therapeutics GAAP EPS of -$0.72 beats by $0.15
|
May 9 |
Q1 2024 Relmada Therapeutics Inc Earnings Call
|
May 9 |
Relmada Therapeutics Inc (RLMD) (Q1 2024) Earnings Call Transcript Highlights: Strategic ...
|